Instantaneous in Vivo Imaging of Acute Myocardial Infarct by NIR‐II Luminescent Nanodots

Sergio Mateos,Jose Lifante,Chunyan Li,Erving C. Ximendes,Tamara Munoz-Ortiz,Jingke Yao,Maria de la Fuente-Fernandez,Angel Luis Garcia Villalon,Miriam Granado,Irene Zabala Gutierrez,Jorge Rubio-Retama,Daniel Jaque,Dirk H. Ortgies,Nuria Fernandez
DOI: https://doi.org/10.1002/smll.201907171
IF: 13.3
2020-01-01
Small
Abstract:Fast and precise localization of ischemic tissues in the myocardium after an acute infarct is required by clinicians as the first step toward accurate and efficient treatment. Nowadays, diagnosis of a heart attack at early times is based on biochemical blood analysis (detection of cardiac enzymes) or by ultrasound-assisted imaging. Alternative approaches are investigated to overcome the limitations of these classical techniques (time-consuming procedures or low spatial resolution). As occurs in many other fields of biomedicine, cardiological preclinical imaging can also benefit from the fast development of nanotechnology. Indeed, bio-functionalized near-infrared-emitting nanoparticles are herein used for in vivo imaging of the heart after an acute myocardial infarct. Taking advantage of the superior acquisition speed of near-infrared fluorescence imaging, and of the efficient selective targeting of the near-infrared-emitting nanoparticles, in vivo images of the infarcted heart are obtained only a few minutes after the acute infarction event. This work opens an avenue toward cost-effective, fast, and accurate in vivo imaging of the ischemic myocardium after an acute infarct.
What problem does this paper attempt to address?